64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
The Daily Biotech Pulse: NRx’s Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours.
Chembio Diagnostics Q3 EPS $(0.24) Misses $(0.22) Estimate, Sales $12.10M Beat $11.50M Estimate
Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 11.11 percent increase over losses of $(0.27) per share
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
Chembio Diagnostic Tweets ‘Biden has announced a new plan for COVID-19 Employers with 100+ workers will now require vaccines or weekly testing Chembio provides tests for Symptomatic & Asymptomatic serial testing, as well as multiplex COVID/Flu testing’
https://twitter.com/ChembioDx/status/1438881607415472128?s=20
20 Stocks Moving in Friday’s Pre-Market Session
Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
Return on Capital Employed Insights for Chembio Diagnostics
After pulling data from Benzinga Pro it seems like during Q2, Chembio Diagnostics (NASDAQ:CEMI) brought in sales totaling $6.46 million. However, earnings decreased 116.23%, resulting in a loss of $8.34 million.
60 Biggest Movers From Friday
Gainers
Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.